Alopecia Pipeline

Inmagene Biopharmaceuticals Announces Positive Phase 2a Trial Results for IMG-007 in Alopecia Areata

April 28, 2025 /

Inmagene Biopharmaceuticals, a clinical-stage company focused on immunological and inflammatory diseases, has announced topline results from its Phase 2a clinical study of IMG-007 in patients with severe alopecia areata. What Is Inmagene Biopharmaceuticals? Inmagene Biopharmaceuticals was founded to advance therapies targeting immune-mediated and inflammatory conditions. The company develops novel monoclonal antibodies and small molecules, aiming…

Androgenetic Alopecia Therapies Master List Pipeline 2025

October 20, 2021 /

This article contains a complete list and description of every known biotech and med-tech company working on a clinical therapy for hair loss prevention/hair growth from all phases spanning research to late-stage clinical trials in 2024/2025. Over the past several years, the amount of new hair growth related technologies in development have multiplied like never…

New Company: Brickell Biotech

November 2, 2017 /

Brickell Biotech, a dermatology-focused pharmaceutical company, is developing a therapy which should prove to be of interest to the online hair community. The company is based in Boulder, CO and has a variety of clinical programs underway in the area of dermatology. One such program is an oral CRTH2 antagonist for hair loss. A “CRTH2…

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.